Investing in Sustainable and Universal Access to Medicines

Local production in developing countries
in partnership with the Joint United Nations Programme on HIV and AIDS, UNAIDS
Session Type
Room number
Room XXV
14 October 2014
15:00 - 18:00 Europe/Zurich

Developing domestic pharmaceutical production capabilities is increasingly seen as a priority for many developing countries. Governments have adopted various strategies to develop their local pharmaceutical production capacities. This session examined three modes of investment in these pharmaceutical companies: namely, the state-owned enterprise, companies with joint-public and private ownership, and completely privately owned companies, and examined their respective strengths and weaknesses in meeting important public health objectives such as access to medicines.

Elements for the debate

  • What are the dynamics of providing access to medicines in developing countries?
  • Is there scope for public endeavour to facilitate access to medicines, particularly to marginalized sections of the population?
  • How can publicly-owned pharmaceutical firms be turned into full-fledged competitors to private sector firms?
  • What means, other than private equity, exist to encourage private pharmaceutical firms to take on board public health concerns?


Secretary-General of UNCTAD
Executive Director, UNAIDS
CEO, CiplaQCIL, Uganda
Board Member, Government Pharmaceutical Organization, Thailand
Chairman of the Board, German Health Care Partnership and Senior Managing Director and Member of the Board, Sysmex Partec GmbH, Germany
Vice President, Fundação Oswaldo Cruz – Fiocruz, Brazil
Minister at the Permanent Mission of South Africa to the United Nations Offices in Geneva
Executive Director, Medicines Patent Pool
Network of People Living with HIV, Netherlands
Senior Industrial Development Officer, UNIDO, Austria
Editor, Journal of Generic Medicines / former CEO, Ranbaxy, United Kingdom
Government Director, Federal Ministry for Economic Cooperation and Development of Germany (BMZ), Germany
Director, Public Health, Innovation and IP, World Health Organisation


CCTV Special Contributor and UNAIDS Goodwill Ambassador and TV Presenter